Last reviewed: April 2026
AI for pathologie digital first approved FDA.
Paige.AI is an AI-powered digital pathology solution that delivers intelligent automation and data-driven insights. It is designed for pathologists, hospital labs, pharma research across the biotechnology and life sciences sector. Founded in 2016, the company is recognized for its automated analysis and consistent scoring.
Paige.AI is best suited for pathologists, hospital labs, pharma research. Enterprise pricing with dedicated support and custom deployment.
Official website: Paige.AI
Compare Paige.AI with other platforms
The platform is designed to address the specific challenges faced by Biotech organizations. Key users include Pathologists, Hospital labs, Pharma research who rely on the platform for fda-cleared pathology ai, prostate cancer detection, gi pathology. In the rapidly evolving Biotech landscape, Paige.AI stands out by combining digital pathology capabilities with industry-specific features that address the unique challenges of fda-cleared pathology ai, prostate cancer detection, gi pathology. The platform enables Pathologists and Hospital labs to transition from manual, error-prone processes to automated, data-driven workflows that deliver consistent results at scale. Compared to alternatives in the digital pathology space, Paige.AI differentiates itself through its focus on Biotech use cases, and Enterprise hospitals that accommodates organizations at different stages of their AI adoption journey.
Before adopting Paige.AI or any Digital Pathology solution for your biotech workflows, it is important to assess how the platform fits your specific requirements. Start by mapping your highest-priority pain points — whether that is reducing manual tasks, improving data accuracy, scaling customer interactions, or accelerating time to insight. Paige.AI positions itself as a Digital Pathology solution, having been in the market since 2016, so evaluate whether its feature set directly addresses those pain points rather than relying on feature-list comparisons alone.
Request a live demo or proof-of-concept trial before committing to an annual contract. During the trial, measure concrete outcomes: task completion time, error rates, user adoption speed, and integration friction with your existing stack. Compare these metrics against at least two alternative vendors in the Digital Pathology space to establish a meaningful benchmark. Paige.AI uses a Enterprise hospitals pricing model — make sure you understand the total cost of ownership including implementation, training, and any per-seat or usage-based fees.
Confirm deployment options meet your IT and compliance requirements. Verify what compliance certifications and data-handling guarantees the vendor provides, especially for regulated biotech environments. Also ask about the vendor's SLA for uptime, support response times, and the data export process should you decide to switch providers in the future.
Paige.AI is a Digital Pathology platform designed for biotech organizations. AI for pathologie digital first approved FDA.
Paige.AI scores 9.1/10 on AI Scanner's independent evaluation. The score reflects performance (30%), usability (25%), pricing value (25%), and versatility (20%). Scores are updated monthly based on product changes, user feedback, and competitive benchmarking across Digital Pathology tools. Read our full scoring methodology.
The top alternative to Paige.AI on AI Scanner is PathAI with a score of 9.3/10. Other alternatives include Proscia, Visiopharm. Compare all alternatives.
Paige.AI is designed for enterprise organizations. Its Enterprise hospitals pricing model scales with team size and usage requirements. We recommend running a pilot with your actual workflows before committing to a full deployment.
Paige.AI uses a Enterprise hospitals pricing model. For the most accurate pricing, request a custom quote directly from the vendor. Pricing may vary based on deployment scale, feature tier, and contract length. Always factor in implementation and training costs when comparing total cost of ownership against competitors.
How We Score: AI Scanner evaluates platforms across four dimensions - Performance (30%), Usability (25%), Pricing Value (25%), and Versatility (20%). Scores are updated monthly. Read our full methodology.